) and a recent meta-analysis of the international literature ) demonstrated how tumour thickn ess could affect both nodal involvement and survival. This evidence led to the proposal of a modified pathological tumour, node, metastasis (pTNM) staging system, in which three cut-offs poin ts for tumour thickness (5, 10 and 20 mm) were combined with the largest tumour dimension to ob tain the pT stage .
Dep th of invasion (DOI) and tumour thickness (TT) are not the same. "Depth of invasion" means the extent of cancer growth in to the tissue beneath an epithelial surface. In cases in which epithelium has been destroyed some inve stigators reconstruct a surface line and measure downwards from it. However, the DOI is sometimes expressed by referring to the microscopic, anatomical deep structures that are reached, rather than by referring to objecti ve micrometer measurements in millimetres (Thompson, 1986 , Breuninger et al., 1990 , Okamoto et al., 2002 . In this case, agreement between pathologists is less readily achieved, because a series of subjective assessments are needed to determine the level of invasion (Breslow, 1977) . By contrast, "tumour thickness" refers to the entire tumour mass; an objective parameter is needed, and the measurement can be obtained using an ocular micrometer.
Proximity to blood vessels and lymphatic s determines the risk of developing nodal metastases, as close proximity facilitates the tumour's ab ility to di sseminate. Therefore, it may be more accurate to consider the actual mass that is presen t beneath the theoretical reconstruction of a basement membrane (DOI), rather than the thickness of the whole tumour (TT). However, measurement of DOI implies assessments that are more subjective. The first step (subjective identification of the deepest in vading tu mour cell) is the same for both DOI and TT. Next, for DOI, a series of subjective assessments are needed, whereas for TT objective measurement can be undertaken. Therefore, TT should be considered a more objective and reproducible parameter.
Studies on microinvasive oral carcinomas have mainly focused on nodal involvement and survival, whereas, to ou r knowledge, no stu dies have examined a Deleted: even if depth of invasion has been felt to be more important than the tumour thickness, measurement of the depth on invasion implies more subjective assessments such as the reconstruction of the adjacent intact mucosa line or of the basement membrane line. 
MATERIAL A N D M E T HO DS
A retrospective stu dy was performed on patients surgically treated for clinical stage I (cT1N0M0) oral squamous cell carcinoma (OSCC) at the Oral Medicine and Oral Oncology Section of the University of Turin.
Patients with previous upper-aero digesti ve tract cancer, or those who had been treated b y adjuvant or neo-adjuvant therapies other than surgery to the neck, were excluded.
Preoperative stagin g was based on clinical examination (palpation) and imaging data. Each patient was assessed by ultrasonography (US) and at least one other imaging technique (computed tomography (CT) or magnetic resonance (MRI)). Lymph nodes with abnormal appearance suggestive of metastases were diagnosed by established criteria (Sakai et al., 2000) , including nodal si ze( >15 mm for levels I and II, > 10 mm for levels III-V). In addition, any lymph node with a central lucency th at suggested necrosis was considered malignant, regardless of its size; conversely, lymph nodes of border line size (10-15 mm for levels I and II and 8-10 mm for levels III-V) were considered positive if th ere were other signs suggestive of malignant involvement such as nodes spherical in shape (rather than being flat or bean-shaped), rim enhancement with central necrosis or cystic degeneration, and presence of abnormally grouped lymph nodes.
Assessment of tumour thickness
To devise a more objective measurement procedure it was decided to define microinvasiveness using TT rather th an DOI. Various cut-off values for TT and DOI have been proposed in the literature, with 4 and 5 mm being the most frequently used. In the absence of an in ternational consensus on the cut-off value to be used, in the present study a cu t-off value of 4 mm for TT used to define microinvasive lesions. To obtain a standardized assessment of the TT, an experienced pathologist blindly reviewed the histological slides of all the selected cases. Thickne ss was measured by an optical micrometer, measuring from the surface to the maximum depth of the tu mour (Figure 1 ). Using the cut-off value of 4mm, a subgroup of microinvasive lesions was iden tified.
Clinical data Data such as gender, age, risk habits (tobacco and/or alcohol), clinical appearance of the lesion/s (e.g. flat or patches, plaques, verrucous lesions and/or erosions/ulcers and lesion site were collected from the patien ts' records. The histological type of the mucosa (thin, vestibular or masticatory), location in the oral cavity (anterior/posterior), symptoms and outcome, were all recorded.
Lesion s were considered symptomatic if there was an y sen sation inducing the patien t to visit a doctor. The anterior/posterior location was defined by referring to an imaginary coronal plane passing th rough the premolar area. The motivation for the visit was defined as "referred by dentist" in cases of incidental findings of asymptomatic lesions, which were occasionally observed during routine dental visits or treatments and prompted a referral.
Smoking habit was recorded as positive for both active and former smokers.
The use of smokeless (e.g. chewing) tobacco was not considered as the practice is almost non-existen t in Italy. The consumption of at least one alcoholic unit per day (1 unit = 8-10 g of ethanol = 1 glass of wine = ¼ litre of beer = 1 measure of liqueur) was considered alcohol exposure. Data on treatmen t methods and delayed nodal involvement or cancer-related deaths were obtained from the follow-up clinical charts.
Statistical analysis
Comparisons between dichotomous variables were assessed by using the chisquare test with Yates correction or the Fisher's exact test, and analysis of variance (ANOVA) was used to test for comparability of age (having proved normal distribution of values). Survival was calculated b y Kaplan-Meier analysis using the log-rank test. All the statistical procedures were performed using the SPSS 17.0 software package (Apache Software Foundation, C hicago, IL, USA). A pvalue of less than, or equal to, 0.05 was considered significant. 
RESULTS
In total, 99 patients (56 men and 43 women), surgically treated for stage I OSCC, were retrieved from the computerized patien t database. Mean age at diagnosis was 64.2 years (range 30 to 92 years, median 67 years). Gender was a significant parameter for risk habits: both tobacco (p=0.007) and alcohol (p=0.002) consumption were more common in men, but no differences were observed in age (p=0.892) or presence of symptoms (p=0.596).
Lesions were located on the ven tral tongue/tongue border (54/99; 54.5%), erosions rather than as ulcers or verrucous lesions (p=0.008). They were also more likely to be diagnosed either as the results of an incidental finding during routine dental vi sits or during follow-up visits for premalignant disorders, rather than because of presence of symptoms (p=0.029). To plan for surgical resection, clinical, histological and imaging (US, CT, MRI) data were used. The traditional policy at our unit for management of the clinically negative n eck in T1 OSCC has generally been a "wait-and-see" policy, thus in the present series, elec tive neck dissection (END) was performed only in cases with borderline nodal features and/or tumour size at preoperative staging or in the presence of poorly differentiated lesion s. END (levels I-III) was performed in 18/99 (18.2%) patien ts, corresponding to six microinvasive and 12 non-microinvasive lesions: five cases (all non-microinvasive) were diagnosed as pN+. As stated above, none of the remaining 81 patients had undergone adjuvant or neo-adjuvant therapies other than surgery to the neck.
Patients were followed up with clin ical evaluation and US every 3 months for the first 36 months, every 6 months for the following 36 months, and then once a year. Chest X-ray was performed once a year. Further assessments (CT, MRI, US-guided fine-needle aspiration biopsy) were performed in cases of positive or suspicious resul ts at routine evaluations. The median follow-up was 4.5 years (mean 5.3, range 0.3 to 13.3); during that period, nine regional recurrences (9.1%) and five cancer-related deaths (5.1%) were recorded. Regional recurrence occurred in 1/32 patients (3.1%) with microinvasive lesions and in 8/67 (11.9%) with non-microinvasive lesions; cancer-related death occurred in 1/32 patients (3.1%) with microinvasive lesions and in 4/67 (6.0%) with non-microinvasive lesions. Kaplan-Meier curves gave a 5-year disease-specific survival rate for stage I OSCC of 95%; 96% for microinvasive lesions and 94.5% for non-microinvasive lesions (p=0.550). Conversely, a recurrence time (mean±SD) of 2.3±2.5 years for 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 In agreement with data from international literature , O-charoenrat et al., 2003 , we observed OSCC lesions more frequently in thin mucosa, with the tongue and the floor of the mouth being the most frequently affected sites. Notably, the buccal mucosa was also a relatively frequently affected site in the present series.
The present data confirmed that TT is significantly related to the clin ical appearance of early stage lesions: "thin" lesions were similar to premalignant lesions, presenting as erosions, patches and plaques, whereas the "th ick" lesions were more likely to be ulcerated, with a low prevalence of erosions and/o r patches. This stresses the importance of careful diagnostic evaluation of any apparently premalignant lesions.
Reports in the liter ature indicate that symptoms are uncommon in the earlier stages, thus early diagnosis of asymptomatic OSCC requires a high clinical index of suspicion. Conversely, symptomatic lesion s are more readily diagnosed because a patien t experiencing any discomfort will direct the clinician to the primary lesion (Mash berg & Samit, 1995) .
In the present series of 99 patients with Stage I OSCC, it was possible to identify the basis of diagnosis in 70 cases: the correct diagnosis was reached for almost half the patients, through an accurate clinical examination. In total, 36/70 diagnoses (51.4%) were made during the follow-up for potentially malignant disorders, or occasionally, through detection of asymptomatic lesions. The issue of early diagnosis is even more important for microinvasive lesions; in the present series, only 11/32 (34.4%) diagnosed lesions produced symptoms (p=0.029). It is noteworthy that 11/32 (34.4%) lesions were referred to our atten tion as an incidental finding during dental visits, th us highlighting the importance of dental practice as an essen tial aid in th e early detection of suspicious intraoral lesions. Nevertheless, symptom s must be interpreted with care. As early cancer has frequently been reported to be asymptomatic, the presence of symptoms that are not strongly indicative of carcinoma, (such as those indicating non-specific inflammation, trauma, or other benign condition s) might induce general practitioners to interpret the symptoms incorrectly and consequently, fail to refer the patien ts for investigation, resulting in diagnostic delay.
The international literature reports significant links between the delay in diagnosis and location of the lesion on the less visibl e surfaces of the oral cavity . In the present series, the microinvasive lesions occurred more frequently on the anter ior sites, but this did not reach significance (p=0.480). However, it is noteworth y that when anterior or posterior cases were considered separately, the presence of symptoms was frequently related to a diagnosis of anterior lesions (p=0.055; data not shown).
Consequently, the p resence of symptoms did not seem to b e helpful in achievin g an early diagnosis in posterior (less visib le) tumour lesions.
To date, there are no universally accepted guidelines for the treatment of clinically negative nodes in early stage OSCC, and use of END is a continuing Deleted: seems to be more Deleted: , Yuen et al., 2009 . Indeed, the decision as to whether to treat the neck nodes depends on tumour and patient factors that are evaluated, on an individual basis, by the surgeon. (Kligerman et al., 1994 , Yuen et al., 2009 , particularly in stage I lesion s (Haddadin et al., 1999 , Dias et al., 2001 ).
In the present series, the improved 5-year disease-specific survival rate observed with END did not reach significance (100% versus 94%; p=0.344), thus these data are not able to support a recommendation for END in Stage I OSCC.
In the full series of 99 Stage I OSCC cases, most of the regional recurrences (8/9; 88.9%) occurred within 2.2 years after surgery. The incidence of nodal recurrences detected during follow-up at 1-2 years post-surgery is confirmed by the literature(Al , and confirms the effectiveness of follow-up in very early stage tu mours also.
The survival analysis for nodal involvem ent confirm s the importance of TT in prognosis. The literature data on TT and nodal involvement in early stage OSCC generally groups patients with stage I and II lesions together, making it difficult to carry out a comparison with the present results. Although numerous studies have assessed the role of TT in nodal involvement (Pen tenero et al., 2005) , it is rarely is it possible to ex tract data from these reports for stage I lesions alone.
We found a slightly lower overall incidence of nodal involvement in Stage I OSCC compared with the studies in the literature (Table 2 ). This may be a result of pooling stage I and II lesions as mentioned previously. Although the literature generally seems to validate the lin k between TT and nodal involvement, not all authors agree on this issue; a recent study comparing TT and Sentinel Node Biopsy (SNB) found that SNB was more reliable than TT in predicting occult disease (Goerkem et al., 2010) .
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